Trial Profile
The Long-term Effect of Marine n-3 Polyunsaturated Fatty Acid Supplementation on Glomerular Filtration Rate and Development of Fibrosis in the Renal Allograft: a Randomized Double Blind Placebo Controlled Intervention Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Oct 2021
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- Acronyms EMiRA
- 03 Oct 2021 Status changed from recruiting to active, no longer recruiting.
- 13 Oct 2020 Planned End Date changed from 31 Aug 2022 to 31 Aug 2025.
- 13 Oct 2020 Planned primary completion date changed from 31 Aug 2022 to 31 Aug 2025.